Biomega Group (‘Biomega’), a leading biosciences company producing high-quality and sustainable salmon ingredients for the human and pet health sectors, has announced the appointment of Stig Victor Petersen as its new Chief Executive Officer, effective 1st October 2020. 


Petersejoins Biomega after more than a decade at the specialty feed company, Hamlet Protein, where he was Vice President of Operations. Prior to his role at Hamlet Group, Petersen held multiple positions across operations, sales, product and application management at several companies, including PalsgaardTetra Pak Filtration and Danisco (DuPont). He brings more than 25 years’ experience in the human nutrition and animal feed industry to the role. 


Petersen commented: “It is a great honour and real pleasure to join the Biomega team as the company accelerates its journey to the next level. With the team’s strong knowhow and commitment to making a positive impact on the world, I am confident that we have the right foundation for future growth. Together with our business partners and customers, we will release the true, untapped potential behind our leading technology for human grade salmon ingredients.”  


The news of Petersen’s appointment follows the Norwegian-based company’s former CEO, Sten Estrup, as he transitions to Chair of the Board at Biomega, effective 1st August 2020. In addition, Estrup will continue as advisor at AMERRA Capital, the New-York based agribusiness investment firm, which acquired Biomega under a private equity deal back in 2017 


“Biomega is expanding outside Norway and we believe that Stig brings the right combination of leadership, relevant skills and excellent experience to execute our current growth strategy,” Estrup saidAs a proven leader, Stig comes with a unique combination of deep commercial food ingredients knowledge, alongside a wealth of experience in operations and project management. Together with our dedicated team, Stig’s passion for this industry will lead Biomega into an even brighter future.” 


From 1st August 2020, the firm’s current Chief Financial Officer, Thomas Samdal, will move into the role of interim CEO until Petersen officially joins the company in October. The company’s current strategy remains unchanged, with continued focus on advancing biotechnology to release the full nutritional and functional value of underutilised side streams in the salmon industry.  


For more information on Biomega and its activities, please visit